Falling morbidity and mortality rates

Growing population and improving demographic indicators

Improving healthcare awareness

Availability of a skilled workforce

Growing healthcare investments, including growing foreign investment in recent years

Market regulations increasingly in line with EU

Government’s commitment to healthcare industry improvements

Low per capita healthcare spending of USD 817 in 2010, putting Turkey in a position behind many European countries

Domestic patent law and intellectual property remaining below international standards

High dependence on the import of hi-tech drugs

Harmonization with the EU and sector modernization leading to considerable potential

Significant scope for growth, given the size of the population and current low consumption rate

Recent introduction of new R&D legislation, designed to facilitate investment

One of the fastest growing markets in the world

Healthcare reforms, such as centralized health insurance/social security, leading to better and wider access to healthcare

Negative effect of government price controls/reimbursement lists on market attractiveness

The costs of modernization to potentially deter the harmonization of the domestic regulatory infrastructure and industry standards with international norms

Need to address the substantial deficit of the healthcare system